Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone spray versus fluocinolone acetonide oral gel for oral lichen planus
TCTR20200731001Phase 2Recruiting
- Sponsor
- Faculty of Dentistry, Srinakharinwirot University
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dexamethasone and fluocinolone in oral lichen planus (OLP) (2 arms), sponsored by Faculty of Dentistry, Srinakharinwirot University. Primary endpoints: Healing of oral lesion at week 4 and Pain at week 4. Started Oct 2019; status: recruiting.
02
Drugs
dexamethasonefluocinolone
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on TCTR20200731001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200731001.